Antibody breaks leukemia's hold, providing new therapeutic approach
Saturday, October 29, 2016 - 05:21
in Health & Medicine
Acute myeloid leukemia (AML) is an aggressive cancer known for drug resistance and relapse. In an effort to uncover new treatment strategies, researchers have discovered that a cell surface molecule known as CD98 promotes AML.